GSK3B and B-cell chronic lymphocytic leukemia: To elucidate the mechanisms by which GSK3β downregulates N1-ICD levels in CLL cells, we examined the effect of GSK3β pharmacologic inhibition on transcriptional expression of NOTCH1 and its downstream targets HES1 and DELTEX (DTX) (n = 12).